We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 26th:
Kala Pharmaceuticals, Inc. (KALA - Free Report) : This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.2% over the last 60 days.
Kopin Corporation (KOPN - Free Report) : This developer of components, subassemblies, head-worn and hand-held systems has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.6% over the last 60 days.
Minerva Neurosciences, Inc. (NERV - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.2% over the last 60 days.
Rayonier Advanced Materials Inc. (RYAM - Free Report) : This producer of natural gas and crude oil has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.6% over the last 60 days
Rayonier Advanced Materials Inc. Price and Consensus
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for May 26th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 26th:
Kala Pharmaceuticals, Inc. (KALA - Free Report) : This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.2% over the last 60 days.
Kala Pharmaceuticals, Inc. Price and Consensus
Kala Pharmaceuticals, Inc. price-consensus-chart | Kala Pharmaceuticals, Inc. Quote
Kala Pharmaceuticals’ shares gained 39.4% over the last one month above the S&P 500’s gain of 6%. The company possesses a Momentum Score of B.
Kala Pharmaceuticals, Inc. Price
Kala Pharmaceuticals, Inc. price | Kala Pharmaceuticals, Inc. Quote
Kopin Corporation (KOPN - Free Report) : This developer of components, subassemblies, head-worn and hand-held systems has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.6% over the last 60 days.
Kopin Corporation Price and Consensus
Kopin Corporation price-consensus-chart | Kopin Corporation Quote
Kopin’s shares gained more than 100% over the last one month. The company possesses a Momentum Score of B.
Kopin Corporation Price
Kopin Corporation price | Kopin Corporation Quote
Minerva Neurosciences, Inc. (NERV - Free Report) : This clinical-stage biopharmaceutical company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 8.2% over the last 60 days.
Minerva Neurosciences, Inc Price and Consensus
Minerva Neurosciences, Inc price-consensus-chart | Minerva Neurosciences, Inc Quote
Minerva Neurosciences’ shares gained 74.2% over the last one month. The company possesses a Momentum Score of B.
Minerva Neurosciences, Inc Price
Minerva Neurosciences, Inc price | Minerva Neurosciences, Inc Quote
Rayonier Advanced Materials Inc. (RYAM - Free Report) : This producer of natural gas and crude oil has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.6% over the last 60 days
Rayonier Advanced Materials Inc. Price and Consensus
Rayonier Advanced Materials Inc. price-consensus-chart | Rayonier Advanced Materials Inc. Quote
Rayonier Advanced Materials’ shares gained more than 76.2% over the last one month. The company possesses a Momentum Score of B.
Rayonier Advanced Materials Inc. Price
Rayonier Advanced Materials Inc. price | Rayonier Advanced Materials Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Biggest Tech Breakthrough in a Generation
Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.
A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.
See 8 breakthrough stocks now>>